Market Tracker

06/23 5:16pm ET

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

23.75
Delayed Data
As of Jun 23
 -0.35 / -1.45%
Today’s Change
9.80
Today|||52-Week Range
25.05
+54.22%
Year-to-Date

Today’s Trading

Previous close24.10
Today’s open24.15
Day’s range23.35 - 24.47
Volume759,346
Average volume (3 months)721,646
Market cap$652.8M
Dividend yield2.82%
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-28.44%
Earnings growth (this year)+30.95%
Earnings growth (next 5 years)+274.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales10,755.10
Price/Book7.75

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...+0.43+2.13%
RETAReata Pharmaceutical...-0.29-0.99%
MGNXMacroGenics Inc-0.08-0.43%
AKBAAkebia Therapeutics ...-0.14-0.85%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$29.0K
Annual profit (last year)-$111.6M
Net profit margin-384,951.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, COO, Director &
CMO
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts